Moreover, this evaluation occurred prior to the COVID-19 pandemic, which has dramatically changed the case-mix in ICUs across the world, hampering both infection control and antimicrobial stewardship initiatives, with many COVID-19 ICU patients now receiving steroids and IL-6 inhibitors as part of their management. This evidence concerns the gene IL6 and COVID-19.